SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-22-008983
Filing Date
2022-04-14
Accepted
2022-04-14 17:01:00
Documents
3
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A mbrx20220406_def14a.htm DEF 14A 501261
2 mbrx20220406_def14aimg001.jpg GRAPHIC 75816
3 mbrx20220406_def14aimg002.jpg GRAPHIC 60585
  Complete submission text file 0001437749-22-008983.txt   690361
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37758 | Film No.: 22828054
SIC: 2834 Pharmaceutical Preparations